Home › Macular Degeneration › Pennsylvania
Macular Degeneration clinical trials in Pennsylvania
17 studies for Macular Degeneration are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Erie Retina Research, Erie
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148A Study in Adults With Geographic Atrophy
- Erie Retina Research, Erie
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Mid Atlantic Retina (Site 050), Bethlehem
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Sep 18, 2026 · NCT07440225A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Mid Atlantic Retina, Bethlehem
- Erie Retinal Surgery & Erie Retina Research, Erie
- Mid Atlantic Retina, Wills Eye Hospital, Philadelphia
- and 2 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
- Erie Retina Research, Erie
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Sep 16, 2026 · NCT07811726Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Erie Retina Research, LLC (Clinic), Erie
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- Mid Atlantic Retina, Bethlehem
RecruitingObservational study
Ages 55 and older · All sexes · Updated Sep 3, 2026 · NCT07144137A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Mid-Atlantic Retina, Philadelphia
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Wills Eye Physicians - Mid Atlantic Retina, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Mid Atlantic Retina, Bethlehem
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Aug 21, 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Erie Retina Research, Erie
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
- Erie, PA, Erie
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Jul 7, 2026 · NCT07587515High Resolution Retinal Imaging
- University of Pennsylvania, Philadelphia
RecruitingObservational studyHealthy volunteers welcome
Ages 7 and older · All sexes · Updated May 5, 2026 · NCT01866371Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Erie Retina Research, Erie
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
- Erie Retina Research, Erie
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Mar 27, 2026 · NCT06924021Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
- CBCC Global Research Site:002, Erie
- CBCC Global Research Site:007, Philadelphia
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Feb 7, 2025 · NCT06132035Novel Glaucoma Diagnostics
- Wills Eye Hospital, Philadelphia
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 15, 2024 · NCT00286637From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.